Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Xiangmei Chen, MD.&Ph.D
CONTACT
Lead
Shenzhen Salubris Pharmaceuticals Co., Ltd.
The eligible subjects screened will be stratified by treatment history and randomized to the 2, 3, 4 mg dose groups in a 1:1:1 ratio. After receiving the initial doses of 2, 3, 4 mg/day for 4 weeks, the subjects will enter a 12-week maintenance treatment period with a total of 7 scheduled visits.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted